What does GoHealth do?
GoHealth, Inc. is a Nasdaq-listed health insurance marketplace focused primarily on Medicare. Rather than underwriting medical risk itself, the company helps consumers compare plans, understand benefits, complete enrollments, and remain engaged after enrollment. Its economic role sits between Medicare beneficiaries and insurance carriers: consumers receive guidance without paying GoHealth directly, while carriers pay commissions or service fees for approved enrollments and related member-support activity.
Where does the company sit in the healthcare value chain?
The company combines digital acquisition, comparison technology, licensed agents, carrier connectivity, enrollment operations, and post-enrollment support. Its consumer-facing website says more than 10 million consumers have trusted GoHealth, while the investor-relations description calls it a Medicare-focused digital health company. The distinction matters: GoHealth is not merely a lead generator, but it is also not a health plan. It is an intermediary whose value depends on matching accuracy, agent productivity, carrier relationships, compliance, and the persistence of enrolled members.
GoHealth’s current model is described in its official Encompass overview and its investor-relations overview.
How does GoHealth make money?
GoHealth earns revenue principally from health-plan partners. A completed submission may be an approved Medicare application, an agent transfer through the Encompass model, or an approved GoHealth Protect application with payment information received by the partner. The company therefore monetizes successful distribution and service outcomes rather than charging the beneficiary a subscription or transaction fee.
What are the main revenue streams?
| Revenue mechanism | Economic logic | Main sensitivity |
|---|---|---|
| Agency commissions | Payments tied to approved enrollments and expected policy persistence. | Carrier commission rates, retention, plan fit, and Medicare enrollment demand. |
| Non-agency / Encompass arrangements | Fees or revenue-sharing tied to transfers, services, or carrier-specific operating models. | Carrier mix, contract structure, and health-plan appetite for outsourced distribution. |
| GoHealth Protect | Revenue from supplemental products introduced in 2025 to broaden monetization beyond core Medicare Advantage. | Product adoption, cross-sell conversion, and partner economics. |
| Renewal economics | Persisting members can produce future commissions or improve lifetime value without repeating all acquisition costs. | Member retention, carrier plan changes, and regulatory rules. |
Why do submissions and unit economics matter?
Management tracks Sales per Submission and Direct Operating Cost per Submission because they connect revenue quality with the cost of generating and servicing each enrollment outcome. Marketing and advertising, consumer care and enrollment, and revenue-share expense are the most visible operating levers. In FY2025 those costs were $116.4 million, $106.0 million, and $96.1 million, respectively. A marketplace can grow submissions yet destroy value if acquisition and service costs exceed expected commission lifetime value; conversely, better matching and retention can improve economics even at lower gross volume.
What did GoHealth’s latest annual results show?
The latest complete official reporting package is FY2025, released March 31, 2026. It showed a sharp contraction and a major impairment cycle, not a normal growth year. Net revenue fell as GoHealth scaled back Medicare Advantage activity in response to tighter carrier economics. The company also launched GoHealth Protect, but that newer product did not offset the reduction in the core business.
How did FY2025 compare with FY2024?
| Metric | FY2025 | FY2024 | Interpretation |
|---|---|---|---|
| Net revenue | $361.8M | $798.9M | A $437.0M contraction as Medicare Advantage activity was reduced. |
| Operating loss | $(412.9)M | $(7.0)M | Impairments and weaker operating scale drove a severe deterioration. |
| Net loss | $(497.8)M | $(7.3)M | Interest expense and asset impairments magnified the operating decline. |
| Adjusted EBITDA | $(35.1)M | $120.3M | The core earnings proxy moved from positive to negative. |
| Interest expense | $87.3M | $72.9M | Debt service became a larger burden against a much smaller revenue base. |
| Impairment charges | $260.0M | $0.0M | The carrying value of assets was reset to reflect weaker expected economics. |
The official 2025 Form 10-K and FY2025 earnings release provide the period data.
Why did GoHealth’s financial structure become the central issue?
GoHealth’s business-model challenge became inseparable from its capital structure. Revenue fell faster than fixed and semi-fixed costs could adjust, while interest expense rose. In August 2025 the company obtained a senior secured superpriority term loan package with $80.0 million of new money and $35.0 million of roll-up loans, waived near-term principal payments through 2026, created up to $250.0 million of debt-basket capacity, issued 4,766,219 Class A shares to lenders, and changed three board seats. Those measures provided time, but they also signaled that ordinary operating cash flow was not sufficient to resolve the leverage problem.
What happened in June 2026?
The filing reported support from 100% of lenders under the relevant debt agreements, more than 60% of outstanding Class A shares, and more than 99% of outstanding GoHealth Holdings LLC units. The restructuring is therefore not merely a remote risk factor; it is the defining current event. The company’s public-equity analysis now depends on the court-approved plan, treatment of existing securities, post-emergence debt, and the operating economics of the reorganized enterprise.
The bankruptcy facts are set out in GoHealth’s June 2026 Form 8-K.
What strategic turning points shaped GoHealth?
GoHealth’s history explains why it owns useful insurance-distribution capabilities yet still encountered severe financial stress. The company repeatedly expanded the scope of the customer journey—from comparison, to enrollment, to Medicare specialization, to post-enrollment engagement—while its economics remained dependent on carrier compensation and the cost of acquiring and servicing consumers.
-
2001Founded as a health-insurance comparison business, creating the data and carrier-connectivity foundation.
-
2013Private-equity backing accelerated investment in technology, marketing, and enrollment operations.
-
2016Entry into Medicare Advantage shifted the company toward an older, high-need customer base with recurring annual plan decisions.
-
2020The IPO funded expansion and Encompass broadened the model beyond a one-time transaction.
-
2022A $50 million strategic investment supported the Medicare-focused platform and balance sheet.
-
2023–2024PlanFit and CARES emphasized personalized matching, activation, engagement, and retention.
-
2025GoHealth Protect launched as core Medicare Advantage activity was reduced; financing and governance were reworked.
-
2026A prepackaged Chapter 11 process sought to resize the capital structure before the annual enrollment period.
What did the strategic evolution fail to solve?
The platform became more sophisticated, but the underlying bargaining structure did not disappear. Carriers can change plan offerings, compensation, approval criteria, and channel priorities. Consumer-acquisition markets can become expensive. Medicare rules can change permissible marketing and enrollment practices. GoHealth therefore built operational depth without achieving complete control over either revenue pricing or customer-acquisition cost.
The company’s official history connects the Medicare pivot, Encompass, PlanFit, and CARES to today’s model.
What gives GoHealth a competitive advantage?
GoHealth’s strongest assets are accumulated insurance-shopping data, licensed-agent operations, technology integrated with carrier workflows, and experience across the Medicare enrollment cycle. The company says its machine-learning algorithms draw on more than two decades of insurance purchasing behavior. That resource can improve matching and routing, while a trained agent organization can handle questions that pure self-service websites cannot.
Is the moat durable?
The moat is qualified rather than absolute. Data improves with transaction volume, but falling volume can weaken that feedback loop. Agent operations create service quality, but also produce large labor and compliance costs. Carrier integration creates switching friction, but carriers retain significant bargaining power. The result resembles a specialized operating capability more than a winner-take-all network effect.
Who are the main competitors?
| Competitive group | Examples | Pressure on GoHealth |
|---|---|---|
| Large online Medicare distributors | eHealth, SelectQuote | Compete for consumer traffic, licensed agents, carrier contracts, and commission economics. |
| Carrier-direct channels | Major Medicare Advantage insurers | Can acquire members without paying an external marketplace and control plan design. |
| Independent agencies and field brokers | Regional and local brokers | Offer relationship-based service and local knowledge with lower central overhead. |
| Benefit platforms and lead networks | Digital comparison and referral businesses | Can bid up leads or specialize in narrower, lower-cost customer journeys. |
Which KPIs best explain GoHealth’s performance?
Revenue alone is insufficient because timing, submission quality, policy persistence, and acquisition cost determine whether an enrollment creates value. The key analytical question is not simply “How many people enrolled?” but “What expected lifetime value remains after the direct cost of finding, advising, enrolling, and retaining each member?”
| KPI | How to interpret it | Why it matters |
|---|---|---|
| Submissions | Approved applications, qualified transfers, or approved GoHealth Protect applications. | The basic volume unit feeding future commissions or service revenue. |
| Sales per Submission | Revenue attributed to each submission. | Captures carrier mix, product mix, commission levels, and expected persistence. |
| Direct Operating Cost per Submission | Marketing, revenue share, and consumer-care costs allocated to each submission. | Shows whether productivity gains are offsetting lower volume or weaker pricing. |
| Policy persistence / retention | How long an enrolled member remains in force or renews. | Longer persistence supports lifetime value and reduces the need to reacquire members. |
| Adjusted EBITDA margin | Adjusted EBITDA divided by net revenue. | Measures whether marketplace economics cover corporate and technology infrastructure. |
| Interest expense / revenue | FY2025 interest expense of $87.3M divided by $361.8M revenue was about 24.1%. | Shows why capital structure overwhelmed operating recovery. |
What cost ratios should researchers monitor?
Who owns GoHealth, and how does governance matter?
GoHealth retains an Up-C structure. GoHealth, Inc. is the public holding company and sole managing member of GoHealth Holdings, LLC; its principal asset is its interest in that operating entity. Class A shares represent the publicly traded economic security, while Class B shares are paired with LLC interests and carry voting rights but no direct dividend participation. As of March 24, 2026, 16,225,250 Class A shares and 12,620,884 Class B shares were outstanding.
What changed after the 2025 financing?
| Governance or ownership fact | Official period | Why it matters |
|---|---|---|
| 16,225,250 Class A shares outstanding | March 24, 2026 | Represents the listed equity base before the restructuring outcome. |
| 12,620,884 Class B shares outstanding | March 24, 2026 | Reflects continuing owners’ voting structure alongside LLC interests. |
| 4,766,219 Class A shares issued to lenders | August 2025 financing | Aligned lenders with equity but diluted prior Class A holders. |
| Three directors appointed and three resigned | August 2025 | Shifted board influence toward stakeholders involved in the capital solution. |
| Co-founders served as co-chairmen | 2025 Form 10-K | Preserved founder presence while management pursued restructuring alternatives. |
| No expected common dividend | 2025 Form 10-K policy | Cash was intended for operations, growth, and debt repayment. |
Preferred securities further complicate the capital stack. Series A redeemable convertible preferred stock ranks senior to common shares for dividends and accrues at 7% annually, while the tax receivable agreement may require payments equal to 85% of qualifying realized tax benefits. These claims matter because enterprise value can exist even when little or none flows to a legacy common class.
GoHealth’s official filings page provides current governance and capital-structure documents.
What opportunities and risks could change the story?
The opportunity case rests on operational assets surviving the balance-sheet reset. Medicare remains complex, consumers still need help comparing networks and medicines, and carriers still need efficient distribution. A reorganized GoHealth with lower debt could use PlanFit, Encompass, CARES, and GoHealth Protect to emphasize better-fit enrollments, retention, cross-sell, and service revenue instead of maximizing raw Medicare Advantage volume.
Where could recovery come from?
Which risks are most material?
| Risk | Financial transmission | What to monitor |
|---|---|---|
| Restructuring execution | Existing equity may be diluted, impaired, or cancelled; emergence could be delayed. | Confirmation order, effective date, new securities, and post-emergence debt. |
| Carrier concentration and bargaining power | Lower commissions or fewer plans reduce Sales per Submission. | Carrier mix, contract renewals, and channel compensation. |
| Medicare regulation | Marketing, enrollment, consent, and compensation rules can raise cost or reduce conversion. | CMS broker rules and annual enrollment requirements. |
| Telemarketing and privacy compliance | TCPA, Do-Not-Call, CAN-SPAM, and privacy claims can create fines and litigation expense. | Consent practices, complaint trends, and legal reserves. |
| Acquisition-cost inflation | Higher lead prices compress contribution economics before corporate overhead. | Marketing cost per submission and channel productivity. |
| Technology and cybersecurity | Disruptions can halt enrollment, expose sensitive data, and damage carrier trust. | Security controls, outages, incidents, and remediation spending. |
Why is GoHealth difficult to value with a standard DCF?
A standard equity DCF assumes a reasonably stable capital structure and a credible path from operating forecasts to cash available for common shareholders. GoHealth does not currently satisfy that simplifying assumption. The June 2026 Chapter 11 filing means the priority of claims and the reorganization plan determine who owns the post-emergence cash flows.
What should a valuation model include?
The most sensitive forecast variables are carrier compensation, submission volume, retention, direct operating cost per submission, and the amount of fixed cost retained after emergence. Terminal value deserves a high risk adjustment because Medicare distribution rules and carrier channel strategy can change faster than a mature consumer-staples model. A comparable-company analysis should also distinguish enterprise value from the value of any specific pre-reorganization security.
What is the key takeaway from GoHealth analysis?
GoHealth built a real operating platform around a difficult consumer problem: Medicare beneficiaries must compare complex combinations of premiums, benefits, provider networks, medicines, and supplemental needs. The company’s technology, licensed agents, carrier connectivity, PlanFit matching, Encompass journey, and CARES engagement model are meaningful capabilities. They explain why a reorganized business could remain strategically useful to carriers and consumers.
Yet the financial evidence is decisive. FY2025 revenue fell to $361.8 million from $798.9 million, adjusted EBITDA moved to a $35.1 million loss, interest expense reached $87.3 million, and impairments totaled $260.0 million. Those pressures culminated in a creditor-supported Chapter 11 filing on June 7, 2026. The central research question is no longer whether the pre-2026 company can simply resume growth; it is whether the post-emergence enterprise can produce durable contribution margins with a sustainable debt load.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
